DE60041340D1 - Identifizierung des plasmodium falciparum erythrozn zum chondroitin sulfat a vermittelt - Google Patents

Identifizierung des plasmodium falciparum erythrozn zum chondroitin sulfat a vermittelt

Info

Publication number
DE60041340D1
DE60041340D1 DE60041340T DE60041340T DE60041340D1 DE 60041340 D1 DE60041340 D1 DE 60041340D1 DE 60041340 T DE60041340 T DE 60041340T DE 60041340 T DE60041340 T DE 60041340T DE 60041340 D1 DE60041340 D1 DE 60041340D1
Authority
DE
Germany
Prior art keywords
chondroitin sulfate
erythrozn
mediated
identification
plasmodium falciparum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60041340T
Other languages
English (en)
Inventor
Arthur Scherf
Louis H Miller
Benoit Gamain
Dror I Baruch
Pierre Buffet
Christine Scheidig
Jurg Gysin
Bruno Pouvelle
Nbbutaka Fujii
Joseph Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE60041340D1 publication Critical patent/DE60041340D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445—Plasmodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE60041340T 1999-09-01 2000-09-01 Identifizierung des plasmodium falciparum erythrozn zum chondroitin sulfat a vermittelt Expired - Lifetime DE60041340D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15202399P 1999-09-01 1999-09-01
PCT/US2000/024195 WO2001016326A2 (en) 1999-09-01 2000-09-01 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a

Publications (1)

Publication Number Publication Date
DE60041340D1 true DE60041340D1 (de) 2009-02-26

Family

ID=22541238

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60041340T Expired - Lifetime DE60041340D1 (de) 1999-09-01 2000-09-01 Identifizierung des plasmodium falciparum erythrozn zum chondroitin sulfat a vermittelt

Country Status (7)

Country Link
US (1) US6855323B2 (de)
EP (1) EP1212423B1 (de)
AT (1) ATE420179T1 (de)
AU (1) AU7345500A (de)
DE (1) DE60041340D1 (de)
DK (1) DK1212423T3 (de)
WO (1) WO2001016326A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703386D0 (sv) * 1997-09-19 1997-09-19 Karolinska Innovations Ab Malaria polypeptides
AU2001277513B2 (en) * 2000-05-31 2006-09-21 Centre National De La Recherche Scientifique Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes
WO2002066515A1 (en) * 2001-02-23 2002-08-29 Institut Pasteur Generation of monoclonal antibodies to poorly immunogenic antigens expressed or carried by eukaryotic cells, use of monoclonal antibodies for therapeutical, diagnostic or vaccine applications
AU2003291977A1 (en) 2003-01-27 2004-08-23 Kobenhavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
WO2006039652A2 (en) * 2004-09-30 2006-04-13 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chondroitin sulfate a binding domains
DE602006015985D1 (de) 2005-09-30 2010-09-16 Philadelphia Health & Educatio Antigene gegen das leberstadium von plasmodium
CN102618538B (zh) * 2011-01-26 2015-05-20 中国人民解放军第二军医大学 一种调控真核生物基因转录的dna序列及其结合蛋白
BR112014018630A2 (pt) * 2012-02-09 2017-07-04 Var2 Pharmaceuticals Aps alvejamento de glicanos de sulfato de condroitina
HU230341B1 (hu) 2012-04-20 2016-02-29 Advancell Diagnosztika Kft. A vörösvérsejt-membrán kvantitatív biomarkerei
CN109387627B (zh) * 2018-10-16 2021-09-24 中国科学院深圳先进技术研究院 一种基于胎盘样硫酸软骨素a的癌症筛查和早期诊断的试剂方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US5993827A (en) * 1993-09-10 1999-11-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins

Also Published As

Publication number Publication date
ATE420179T1 (de) 2009-01-15
US20040062769A1 (en) 2004-04-01
EP1212423A2 (de) 2002-06-12
DK1212423T3 (da) 2009-04-27
WO2001016326A3 (en) 2001-08-23
WO2001016326A2 (en) 2001-03-08
AU7345500A (en) 2001-03-26
EP1212423B1 (de) 2009-01-07
US6855323B2 (en) 2005-02-15

Similar Documents

Publication Publication Date Title
ATE190357T1 (de) Schnelles verfahren fur die dns sequenzierung und diagnostische anwendungen
WO2004028341A3 (en) Susceptibility gene for human stroke; methods of treatment
IL172506A0 (en) New biological entities and the use thereof
MY138759A (en) Treatment of huntington's disease with epa
AU2003284891A1 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
DE60010702D1 (de) Behandlung von titanerz zur herstellung von titandioxidpigmenten
AU2003259285A8 (en) Methods of identifying adipocyte specific genes, the genes identified, and their uses
MXPA02004333A (es) Uso de genomas haploides para diagnostico, modificacion y multiplicacion genetica.
HUP0301600A2 (hu) Humán köldökzsinórvér-eredetű nem korlátozott szomatikus őssejtek (USSC)
AU2003299585A8 (en) Water-soluble products and methods of making and using the same
IN2014DN02484A (de)
DE60041340D1 (de) Identifizierung des plasmodium falciparum erythrozn zum chondroitin sulfat a vermittelt
WO2002044736A3 (en) Diagnosis and treatment of epidermal or skin diseases
DE10295664D2 (de) Verfahren zum Nachweis von Morbus Alzheimer und zur Unterscheidung von Morbus Alzheimer gegenüber anderen demenziellen Erkrankungen, zugehörige Paptide und deren Verwendungen
AU2003293141A1 (en) Methods for identifying risk of breast cancer and treatments thereof
MXPA01010403A (es) Agentes quimiotacticos e inhibidores derivados de osteopontina y usos de los mismos.
DE60141654D1 (de) Verfahren für die herstellung von heterorylaminderivaten
NZ511366A (en) Virulence genes and proteins, and their use
DE69838615D1 (de) ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN
DE60042753D1 (de) Von antibiotika
AU2001240820A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
AU2003298570A8 (en) Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
DE69916829D1 (de) Genetisch veränderte fibroblasten und ihre verwendung
DE69938427D1 (de) Tes gen und dessen verwendung
FR2837833B1 (fr) Procede de culture en masse, de la diatomee "haslea ostrearia simonsen" et utilisation des cultures obtenues par le procede

Legal Events

Date Code Title Description
8364 No opposition during term of opposition